Association between number of medications and mortality among older adult patients in a specialized cardiology hospital

被引:1
作者
Arita, Takuto [1 ]
Suzuki, Shinya [1 ]
Yagi, Naoharu [1 ]
Otsuka, Takayuki [1 ]
Kishi, Mikio [1 ]
Kano, Hiroto [1 ]
Matsuno, Shunsuke [1 ]
Kato, Yuko [1 ]
Uejima, Tokuhisa [1 ]
Oikawa, Yuji [1 ]
Matsuhama, Minoru [2 ]
Iida, Mitsuru [2 ]
Yajima, Junji [1 ]
Yamashita, Takeshi [1 ]
机构
[1] Cardiovasc Inst, Dept Cardiovasc Med, Tokyo, Japan
[2] Cardiovasc Inst, Dept Cardiovasc Surg, Tokyo, Japan
关键词
cardiovascular; mortality; older adult; polypharmacy; ATRIAL-FIBRILLATION; POLYPHARMACY; RISK; PREVALENCE; CRITERIA; OUTCOMES; THERAPY; COHORT; JAPAN;
D O I
10.1111/ggi.14275
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aim Although polypharmacy has been associated with poor clinical outcomes, whether taking an increased number of medications is harmful or beneficial for older adult patients treated for cardiovascular diseases might require further discussion. Methods We analyzed data of 2089 patients aged >= 75 years in a single hospital-based cohort. The study population was divided into three groups according to the tertiles of the number of medications at baseline: <3 (n = 647), 3-7 (n = 707) and >= 8 (n = 735). Results The cumulative incidences of all-cause death at 3 years among patients taking less than three, three to seven and eight or more medications were 3.7%, 4.1% and 7.8%, respectively (log-rank test P = 0.015). In a Cox regression analysis, taking eight or more total medications (vs 0-2) was independently associated with all-cause death (hazard ratio 1.67, 95% CI 1.01-2.78). For predicting mortality using the number of medications, the maximum Youden Index was 7. In subgroups with certain heart diseases, no regular tendency of an increase in the risk of all-cause death was observed with an increase in the number of medications. Conclusions The number of medications taken was independently associated with mortality among older adult patients, with a relatively high cut-off point. This association was not observed in patients with certain heart diseases, possibly indicating the merit - rather than the harm - of medical treatment in the cardiovascular field. Geriatr Gerontol Int 2021; center dot center dot: center dot center dot-center dot center dot.
引用
收藏
页码:985 / 995
页数:11
相关论文
共 30 条
[1]   A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting [J].
Alhawassi, Tariq M. ;
Krass, Ines ;
Bajorek, Beata V. ;
Pont, Lisa G. .
CLINICAL INTERVENTIONS IN AGING, 2014, 9 :2079-2086
[2]   Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study [J].
Appleton, Sarah C. ;
Abel, Gary A. ;
Payne, Rupert A. .
BMC FAMILY PRACTICE, 2014, 15
[3]   Frailty, Polypharmacy, and Health Outcomes in Older Adults: The Frailty and Dependence in Albacete Study [J].
Bonaga, Beatriz ;
Sanchez-Jurado, Pedro M. ;
Martinez-Reig, Marta ;
Ariza, Gabriel ;
Rodriguez-Manas, Leocadio ;
Gnjidic, Danijela ;
Salvador, Transito ;
Abizanda, Pedro .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2018, 19 (01) :46-52
[4]   Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of Acute Kidney Injury in Elderly Patients [J].
Chao, Chia-Ter ;
Tsai, Hung-Bin ;
Wu, Chia-Yi ;
Lin, Yu-Feng ;
Hsu, Nin-Chieh ;
Chen, Jin-Shin ;
Hung, Kuan-Yu .
MEDICINE, 2015, 94 (31)
[5]   Suboptimal medication use and mortality in an older adult community-based cohort: Results from the Hispanic EPESE study [J].
Espino, DV ;
Bazaldua, OV ;
Palmer, RF ;
Mouton, CP ;
Parchman, ML ;
Miles, TP ;
Markides, K .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2006, 61 (02) :170-175
[6]   Updating the beers criteria for potentially inappropriate medication use in older adults - Results of a US consensus panel of experts [J].
Fick, DM ;
Cooper, JW ;
Wade, WE ;
Waller, JL ;
Maclean, JR ;
Beers, MH .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (22) :2716-2724
[7]  
Frazier Susan C, 2005, J Gerontol Nurs, V31, P4
[8]   Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes [J].
Gnjidic, Danijela ;
Hilmer, Sarah N. ;
Blyth, Fiona M. ;
Naganathan, Vasi ;
Waite, Louise ;
Seibel, Markus J. ;
McLachlan, Andrew J. ;
Cumming, Robert G. ;
Handelsman, David J. ;
Le Couteur, David G. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2012, 65 (09) :989-995
[9]   Clinical pharmacology in the geriatric patient [J].
Hilmer, Sarah N. ;
McLachlan, Andrew J. ;
Le Couteur, David G. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 (03) :217-230
[10]   Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial [J].
Focks, Jeroen Jaspers ;
Brouwer, Marc A. ;
Wojdyla, Daniel M. ;
Thomas, Laine ;
Lopes, Renato D. ;
Washam, Jeffrey B. ;
Lanas, Fernando ;
Xavier, Denis ;
Husted, Steen ;
Wallentin, Lars ;
Alexander, John H. ;
Granger, Christopher B. ;
Verheugt, Freek W. A. .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 353